These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 21175851

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. SLC40A1 c.1402G-->a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype.
    Lee PL, Gelbart T, West C, Barton JC.
    Acta Haematol; 2007; 118(4):237-41. PubMed ID: 18160816
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rare types of genetic hemochromatosis.
    Camaschella C, Poggiali E.
    Acta Haematol; 2009; 122(2-3):140-5. PubMed ID: 19907151
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Hereditary and acquired iron overload].
    de Korwin JD.
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
    Koyama C, Wakusawa S, Hayashi H, Ueno T, Suzuki R, Yano M, Saito H, Okazaki T.
    Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
    [Abstract] [Full Text] [Related]

  • 14. A previously undescribed frameshift deletion mutation of HFE (c.del277; G93fs) associated with hemochromatosis and iron overload in a C282Y heterozygote.
    Barton JC, West C, Lee PL, Beutler E.
    Clin Genet; 2004 Sep; 66(3):214-6. PubMed ID: 15324319
    [Abstract] [Full Text] [Related]

  • 15. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.
    Shukla P, Julka S, Bhatia E, Shah S, Nagral A, Aggarwal R.
    Natl Med J India; 2006 Sep; 19(1):20-3. PubMed ID: 16570681
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ.
    Hum Mol Genet; 2003 Sep 01; 12(17):2241-7. PubMed ID: 12915468
    [Abstract] [Full Text] [Related]

  • 18. The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta(s)/beta(thal) anemia patients.
    Politou M, Kalotychou V, Pissia M, Rombos Y, Sakellaropoulos N, Papanikolaou G.
    Haematologica; 2004 Apr 01; 89(4):490-2. PubMed ID: 15075083
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload.
    Zaahl MG, Merryweather-Clarke AT, Kotze MJ, van der Merwe S, Warnich L, Robson KJ.
    Hum Genet; 2004 Oct 01; 115(5):409-17. PubMed ID: 15338274
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.